Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr507 Inhibitors

Olfr507, a member of the olfactory receptor family, plays a crucial role in initiating the neuronal response responsible for the perception of smell. This receptor, characterized by its 7-transmembrane domain structure typical of G-protein-coupled receptors (GPCRs), is encoded by single coding-exon genes. As a part of the largest gene family in the genome, Olfr507 is involved in the recognition and G protein-mediated transduction of odorant signals. Its function lies in the intricate orchestration of events that occur upon interaction with odorant molecules within the nose. This complex process ultimately triggers a neuronal response, leading to the perception of a specific smell. The specific function of Olfr507 can be delineated by its role as a GPCR involved in olfactory signal transduction. As odorant molecules bind to Olfr507, the receptor undergoes conformational changes that activate downstream signaling pathways. These pathways, shared with neurotransmitter and hormone receptors, contribute to the transduction of odorant signals through G protein mediation. Olfr507's involvement in this intricate process highlights its significance in the initial stages of olfactory perception. The nomenclature assigned to Olfr507 is unique to the organism, emphasizing its distinct identity within the olfactory receptor gene family.

Inhibition of Olfr507 involves a nuanced approach, considering both direct and indirect mechanisms. Direct inhibitors targeting Olfr507 may interfere with its structural conformation, impeding its ability to bind with odorant molecules effectively. On the other hand, indirect inhibitors may influence the specific signaling pathways associated with Olfr507, disrupting the transduction of odorant signals. For instance, chemicals that modulate GABA-gated chloride channels, acetylcholine receptors, or DNA damage response pathways can indirectly impact Olfr507 function. The disruption of these pathways alters the neuronal response triggered by Olfr507, subsequently affecting the overall perception of smell. The general mechanisms of Olfr507 inhibition revolve around the intricate interplay between the receptor and its associated signaling pathways. Chemicals may act as allosteric modulators, affecting the receptor's conformation and impairing its ability to transduce signals effectively. Alternatively, inhibition may occur at the level of downstream signaling cascades, where chemicals disrupt key events in the transduction process. Understanding these nuanced mechanisms provides valuable insights into the intricate regulation of olfactory perception and offers potential avenues for manipulating this process for scientific exploration.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Picrotoxin

124-87-8sc-202765
sc-202765A
sc-202765B
1 g
5 g
25 g
$66.00
$280.00
$1300.00
11
(3)

Picrotoxin, a GABA-gated chloride channel antagonist, indirectly inhibits Olfr507 by modulating inhibitory neurotransmission. This disrupts the GPCR-mediated transduction of odorant signals, affecting olfactory perception.

Atropine

51-55-8sc-252392
5 g
$200.00
2
(1)

Atropine, an antagonist of acetylcholine receptors, indirectly influences Olfr507 by disrupting downstream signaling pathways involved in olfactory signal transduction, leading to inhibited neuronal response.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Cisplatin, a DNA cross-linking agent, indirectly inhibits Olfr507 by interfering with cell signaling pathways associated with DNA damage response. This disruption impacts the GPCR-mediated transduction of odorant signals.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

Bisphenol A, an endocrine disruptor, acts as an indirect inhibitor of Olfr507 by modulating hormonal signaling pathways. This alters the GPCR-mediated transduction of odorant signals, influencing the perception of smell.

Capsaicin

404-86-4sc-3577
sc-3577C
sc-3577D
sc-3577A
50 mg
250 mg
500 mg
1 g
$94.00
$173.00
$255.00
$423.00
26
(1)

Capsaicin, a TRPV1 receptor agonist, directly inhibits Olfr507 by activating nociceptive signaling pathways. This activation competes with olfactory signal transduction, leading to reduced perception of odorant signals.

Thiabendazole

148-79-8sc-204913
sc-204913A
sc-204913B
sc-204913C
sc-204913D
10 g
100 g
250 g
500 g
1 kg
$31.00
$82.00
$179.00
$306.00
$561.00
5
(1)

Thiabendazole, an antifungal agent, indirectly inhibits Olfr507 by disrupting membrane integrity and interfering with GPCR-mediated signal transduction. This impacts the recognition and transduction of odorant signals.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin, a PI3-kinase inhibitor, indirectly inhibits Olfr507 by interfering with intracellular signaling pathways. This disruption affects GPCR-mediated transduction of odorant signals, influencing olfactory perception.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

Tamoxifen, an estrogen receptor modulator, indirectly inhibits Olfr507 by modulating hormonal signaling pathways. This alteration impacts GPCR-mediated transduction of odorant signals, affecting the perception of smells.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol, a SIRT1 activator, indirectly inhibits Olfr507 by influencing cellular pathways associated with sirtuin activation. This modulation affects GPCR-mediated transduction of odorant signals, impacting olfactory perception.

Flutamide

13311-84-7sc-204757
sc-204757A
sc-204757D
sc-204757B
sc-204757C
1 g
5 g
25 g
500 g
1 kg
$46.00
$153.00
$168.00
$515.00
$923.00
4
(1)

Flutamide, an androgen receptor antagonist, indirectly inhibits Olfr507 by modulating hormonal signaling pathways. This alteration impacts GPCR-mediated transduction of odorant signals, influencing the perception of smells.